HepQuant, LLC continues to expand clinical availability of the HepQuant DuO test to liver specialists in clinical practice, and will present eight abstracts at key upcoming liver conferences, ...
GRIN Therapeutics, Inc., a leader in the development of therapies to treat serious neurodevelopmental disorders, today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug ...